Carlo Dominici

Carlo Dominici

UNVERIFIED PROFILE

Are you Carlo Dominici?   Register this Author

Register author
Carlo Dominici

Carlo Dominici

Publications by authors named "Carlo Dominici"

Are you Carlo Dominici?   Register this Author

51Publications

1014Reads

29Profile Views

Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience.

Childs Nerv Syst 2019 06 21;35(6):1007-1012. Epub 2019 Mar 21.

Department of Radiology Emergency, "Sapienza" University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00381-019-04117-zDOI Listing
June 2019

Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma.

Oncogene 2019 05 22;38(20):3843-3854. Epub 2019 Jan 22.

Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-0699-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544520PMC
May 2019

Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.

Pediatr Hematol Oncol 2014 Aug 16;31(5):400-8. Epub 2014 Jun 16.

1Department of Paediatric Surgery, Institute of Child Health, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2014.912709DOI Listing
August 2014

KIT gene deletion in a gastrointestinal stromal tumor of the small intestine.

J Pediatr Gastroenterol Nutr 2014 Mar;58(3):e25

*Department of Clinical and Molecular Medicine †Department of Hematology ‡Department of Pediatrics, La Sapienza University, Rome, Italy §Children Welfare Teaching Hospital, Baghdad College of Medicine, Iraq.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPG.0b013e318261032aDOI Listing
March 2014

Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients.

J Cyst Fibros 2013 Dec 28;12(6):797-802. Epub 2013 Apr 28.

Department of Experimental Medicine, Sapienza University of Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2013.03.007DOI Listing
December 2013

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

Lab Invest 2013 Oct 2;93(10):1090-9. Epub 2013 Sep 2.

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2013.97DOI Listing
October 2013

Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.

World J Surg 2013 Feb;37(2):459-65

Pediatric Surgery Unit, Department of Pediatrics, Sapienza University of Rome, 324 Viale Regina Elena, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-012-1837-0DOI Listing
February 2013

Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma.

Pediatr Blood Cancer 2012 Oct 9;59(4):627-30. Epub 2012 Jan 9.

Department of Pediatrics, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24072DOI Listing
October 2012

MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

Mol Cancer Res 2011 Jan 20;9(1):67-77. Epub 2010 Dec 20.

Department of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena, 324, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-10-0227DOI Listing
January 2011

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

FASEB J 2009 Dec 27;23(12):4276-87. Epub 2009 Aug 27.

Department of Experimental Medicine and Biochemical Sciences, University of Rome "Tor Vergata," Via Montpellier 1, 00133 Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.09-134965DOI Listing
December 2009

RAS signaling dysregulation in human embryonal Rhabdomyosarcoma.

Genes Chromosomes Cancer 2009 Nov;48(11):975-82

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20702DOI Listing
November 2009

Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.

Anticancer Res 2008 Mar-Apr;28(2A):763-9

Laboratory of Stem Cells, Bambino Gesù Children's Hospital, I-00165 Rome, Italy.

View Article

Download full-text PDF

Source
June 2008

Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.

Biochem Biophys Res Commun 2008 Apr 28;368(2):350-6. Epub 2008 Jan 28.

ENEA Research Center Casaccia, Section of Toxicology and Biomedical Sciences, Via Anguillarese, 301, Rome 00123, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2008.01.093DOI Listing
April 2008

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models.

Int J Cancer 2007 Mar;120(5):1141-9

Department of Oncology, Royal Liverpool Children's NHS Trust Alder Hey, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22391DOI Listing
March 2007

Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells.

Biochem Biophys Res Commun 2006 Dec 18;351(2):547-52. Epub 2006 Oct 18.

ENEA, Research Center Casaccia, Section of Toxicology and Biomedical Sciences, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.10.062DOI Listing
December 2006

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.

Clin Cancer Res 2006 Nov;12(22):6772-80

Section of Toxicology and Biomedical Sciences, Ente per le Nuove tecnologie l'Energia e l'Ambiente, Research Center Casaccia, La Sapienza University, Department of Pediatrics, Laboratory of Oncology, Bambino Gesù Children's Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/clincanres/12/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-1479DOI Listing
November 2006

Antitumor activity of imatinib mesylate in neuroblastoma xenografts.

Cancer Lett 2005 Oct;228(1-2):211-9

Department of Pediatrics, Catholic University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2005.02.054DOI Listing
October 2005

High mobility group A1 is a molecular target for MYCN in human neuroblastoma.

Cancer Res 2005 Sep;65(18):8308-16

Department of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-0607DOI Listing
September 2005

Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma.

J Pediatr Surg 2004 Nov;39(11):1673-9

Department of Pathology, Children's Hospital Bambino Gesu, Research Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2004.07.014DOI Listing
November 2004

Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.

Am J Surg Pathol 2003 Oct;27(10):1386-9

Department of Pathology, Children's Hospital Bambino Gesù, Piazza Sant'Onofrio 4, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200310000-00012DOI Listing
October 2003

Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.

Cancer Res 2002 Jan;62(1):301-6

Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
January 2002